All of the attention has got VCs excited, and companies on both sides of the Atlantic have convinced them to get out their chequebook: Danish startup Embla, which prescribes GLP-1 meds alongside ongoing clinical care and lifestyle advice for patients looking to lose weight in its home market and the UK, picked up a 10m Series A in August 2023 a year on from a 3.5m seed round
From decoding health trends and interviewing doctors to testing fitness routines herself, Tavishi always approaches content with one filter: Will this help someone make a better decision today? Subject expertise With 9+ years tracking Indias health conversations, Tavishi knows the gap between clinical advice and daily life
If your levels were already healthy, a single shot tops you off, and the noticeable effects fade sooner
Amino acid transporters revisited: new views in health and disease
Targeted supplements: Data indicates that calorie intake reduces by 16-39% while taking a GLP1 medication (Spreckley 2026)
They are naturally rich in glutathione